Immediate-type hypersensitivity reactions due to antituberculosis drugs: a successful readministration protocol-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immediate-type hypersensitivity reactions due to antituberculosis drugs: a successful readministration protocol

Published:2015-07 Issue:1 Volume:115 Page:39-44
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Buhari Gözde Köycü,Keren Metin,Dursun Adile Berna,Güler Müjgan,Dulkar Güngör,Kalaç Nilgün,Özkara Şeref,Erkekol Ferda Öner

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference31 articles.

1. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis;Yee;Am J Respir Crit Care Med,2003

2. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis;Schaberg;Eur Respir J,1996

3. Adverse events with isoniazid preventive therapy: experience from a large trial;Grant;AIDS,2010

4. Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis;Gülbay;Respir Med,2006

5. Adverse drug reactions associated with first-line anti-tuberculosis drug regimens;Marra;Int J Tuberc Lung Dis,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Immediate Type Hypersensitivity Reactions with First-Line Antituberculosis Drugs and Diagnostic Patch Testing;ASTHMA ALLERGY IMMUN;2024

2. DRESS syndrome due to anti-TB drugs: A complex case with successful re-desensitization of group A drugs;Journal of Family Medicine and Primary Care;2024-04

3. Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations;World Allergy Organization Journal;2024-01

4. Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization;Allergy, Asthma & Clinical Immunology;2022-11-21

5. Practical management of suspected hypersensitivity reactions to anti‐tuberculosis drugs;Clinical & Experimental Allergy;2022-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3